RA Pharmaceuticals, Inc.
$MIRA is a small biotech stock listed on NASDAQ. The company works on experimental drugs for neurological and mental health conditions.
Current rough facts about it:
💰 Market cap: about $48–50 million
📉 Price range last year: $0.73 – $2.45
🧪 Still early-stage biotech with no real revenue yet
🏢 Founded in 2020, based in Miami
📊 IPO price in 2023 was about $7
Translation: small company, lots of promises, not much proven yet. Classic biotech lottery ticket.
What they’re developing
Main drug projects:
Ketamir-2
Oral ketamine-like drug
Target: depression, PTSD, neuropathic pain
MIRA-55
Non-psychoactive cannabis-based compound
Target: inflammation and pain
SKNY-1
Experimental drug for weight loss and smoking cessation
Why traders watch it
Because tiny biotech stocks move like caffeinated squirrels:
Clinical trial news → price can pump hard
Bad results → dump instantly
Low market cap → very volatile
Honest trader take
If you’re trading it:
It’s speculative
News driven (FDA, trials, partnerships)
Can pump 100–300% on hype but crash just as fast.
#Mira @Mira - Trust Layer of AI
Basically the financial version of buying a lottery ticket with lab equipment attached.
If you’re digging for low-cap runners like ROBO and MIRA, that tells me you’re hunting high-volatility stocks. Risky hobby, but at least it’s more interesting than staring at spreadsheets all day. 📈